Wird geladen...
In Reply
Our meta-analysis provides evidence that zoledronic acid in the adjuvant breast cancer setting may increase survival. Additional data from basic research and clinical trials in the future will help us interpret its role with more confidence.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AlphaMed Press
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755942/ https://ncbi.nlm.nih.gov/pubmed/23986347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0235 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|